Intraprocedural abciximab bolus versus pretreatment oral dual antiplatelet medication for endovascular stenting of unruptured intracranial aneurysms

Conclusions Standalone intraprocedural abciximab bolus was not associated with an increased rate of complications compared with pretreatment with DAPM for unruptured intracranial aneurysm stenting.

http://jnis.bmj.com/cgi/content/short/8/9/909?rss=1

Source: Journal of NeuroInterventional Surgery - August 11, 2016 Category: Neurosurgery Authors: Levitt, M. R., Moon, K., Albuquerque, F. C., Mulholland, C. B., Kalani, M. Y. S., McDougall, C. G. Tags: Hemorrhagic stroke Source Type: research